These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4668902)

  • 21. Observations on the effects of a new diuretic--S1520.
    Goldberg B; Furman KI
    S Afr Med J; 1974 Jan; 48(4):113-8. PubMed ID: 4596126
    [No Abstract]   [Full Text] [Related]  

  • 22. [The saluretic effect of xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylilide) in normal subjects].
    Hempelmann FW; Leuschner F; Liebenow W
    Arzneimittelforschung; 1975 Feb; 25(2):252-5. PubMed ID: 1173042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium appetite elicited by furosemide: effects of differential dietary maintenance.
    Jalowiec JE
    Behav Biol; 1974 Mar; 10(3):313-27. PubMed ID: 4815155
    [No Abstract]   [Full Text] [Related]  

  • 24. Investigation of diuretic and antidiuretic properties of furosemide in diabetes insipidus.
    Radó JP; Bános C; Marosi J; Borbély L; Takó J
    Endokrinologie; 1968; 53(3):253-60. PubMed ID: 5713386
    [No Abstract]   [Full Text] [Related]  

  • 25. Determinants of response to frusemide in normal subjects.
    Branch RA; Roberts CJ; Homeida M; Levine D
    Br J Clin Pharmacol; 1977 Apr; 4(2):121-7. PubMed ID: 861127
    [No Abstract]   [Full Text] [Related]  

  • 26. Implication of thromboxane in frusemide diuresis in rats.
    Melki TS; Foegh ML; Ramwell PW
    Clin Sci (Lond); 1986 Dec; 71(6):647-50. PubMed ID: 3791866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure.
    Olesen KH; Sigurd B; Steiness E; Leth A
    Acta Med Scand; 1973; 193(1-2):119-31. PubMed ID: 4574445
    [No Abstract]   [Full Text] [Related]  

  • 28. Further studies on the sites of action of clopamide and furosemide.
    Rado JP; Szende L; Tako J; Banos C; Borbely L
    J Clin Pharmacol J New Drugs; 1969; 9(2):99-103. PubMed ID: 4305669
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mechanism of kaliuresis after administration of furosemide in men. Clinical possibilities of measuring of distal potassium secretion].
    Schück O; Stríbrná J
    Klin Wochenschr; 1970 Oct; 48(19):1173-80. PubMed ID: 5480411
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of furosemide on the osmolality of the urine and the composition of renal tissue.
    Fraser AG; Cowie JF; Lambie AT; Robson JS
    J Pharmacol Exp Ther; 1967 Dec; 158(3):475-86. PubMed ID: 6073231
    [No Abstract]   [Full Text] [Related]  

  • 31. Diuretic properties of Orthosiphon stamineus Benth.
    Adam Y; Somchit MN; Sulaiman MR; Nasaruddin AA; Zuraini A; Bustamam AA; Zakaria ZA
    J Ethnopharmacol; 2009 Jul; 124(1):154-8. PubMed ID: 19375494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the sites of action of ethacrynic acid and furosemide during angiotensin infusion.
    Rado JP; Szende L; Tako J; Borbely L
    J Clin Pharmacol J New Drugs; 1970; 10(6):375-81. PubMed ID: 4320100
    [No Abstract]   [Full Text] [Related]  

  • 34. [An experimental and clinical pharmacological study of the influence of triamterene on the diuretic and saluretic properties of furosemide xantinol].
    Celdrán E; Bekett PR; Roberts DJ
    Arzneimittelforschung; 1976; 26(11):2073-6. PubMed ID: 14648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trial of mefruside, a new diuretic.
    Auld WH; Murdoch WR
    Br Med J; 1971 Dec; 4(5790):786-8. PubMed ID: 5135250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multivariate analysis in the pharmacological evaluation of a saluretic compound.
    Causa P; Nunziata N; Coscia L; Oriani GA
    Arzneimittelforschung; 1975 Mar; 25(3):413-5. PubMed ID: 1174044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diuretic and antidiuretic effects of furosemide before and during the early period of pitressin therapy in diabetes insipidus.
    Radó JP; Takó J; Szabó T; Bános C
    Endokrinologie; 1969; 54(1):26-35. PubMed ID: 5358572
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of dopamine and its combination with furosemide on urination in the rat].
    Berkhin EB
    Farmakol Toksikol; 1985; 48(2):89-92. PubMed ID: 3996577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 4-Leucine-oxytocin: natriuretic, diuretic, and antivasopressin polypeptide.
    Chan WY; Hruby VJ; Flouret G; Du Vigneuad V
    Science; 1968 Jul; 161(3838):280-1. PubMed ID: 5657333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.